Initiation of vedolizumab did not provoke new-onset spondylarthritis in patients with inflammatory bowel disease: A prospective 24-week study with imaging assessments.

Sherry RohekarTristan BoydRobert G LambertMelanie BeatonNilesh ChandeJamie GregorHeather LennoxKeith McintoshTerry PonichAdam RahmanTrimadhu SharmaMichael SeyMaria TauqirVipul Jairath

Published in: United European gastroenterology journal (2024)

Vedolizumab initiation did not induce new features of axial or peripheral SpA after 24 weeks of treatment in TNF inhibitor-experienced or TNF inhibitor-naive patients with IBD.

Keyphrases

patients with inflammatory bowel disease
rheumatoid arthritis
ulcerative colitis
high resolution
clinical trial
mass spectrometry
smoking cessation
fluorescence imaging